Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin dependent kinase inhibitor 2C | 0.527 | 0.654 | 0.40 |
|
group | 0.400 | None | 0.818 | 0 | 0 | 1993 | 2018 | ||||||||
|
thiopurine S-methyltransferase | 0.593 | 0.692 | 7.1E-06 |
|
group | 0.400 | None | 0.833 | 0 | 0 | 2000 | 2018 | ||||||||
|
glucose-6-phosphate dehydrogenase | 0.424 | 0.846 | 0.97 |
|
group | 0.400 | None | 0.875 | 0 | 0 | 1977 | 2019 | ||||||||
|
5'-nucleotidase, cytosolic II | 0.537 | 0.846 | 2.1E-06 |
|
group | 0.400 | None | 0.900 | 0 | 0 | 2003 | 2019 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
group | 0.400 | None | 0.903 | 0 | 0 | 1998 | 2019 | ||||||||
|
phosphoinositide-3-kinase regulatory subunit 1 | 0.477 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.923 | 0 | 0 | 2001 | 2019 | ||||||||
|
EPH receptor A3 | 0.497 | 0.692 | 1.2E-05 |
|
group | 0.400 | None | 0.933 | 0 | 0 | 2010 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 0.400 | None | 0.941 | 0 | 0 | 1996 | 2019 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.943 | 0 | 0 | 1999 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.944 | 0 | 0 | 1980 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.945 | 0 | 0 | 1992 | 2020 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
group | 0.400 | None | 0.946 | 0 | 0 | 2002 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.600 | None | 0.946 | 0 | 0 | 1994 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
group | 0.400 | None | 0.947 | 0 | 0 | 1995 | 2018 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.400 | None | 0.955 | 0 | 0 | 1983 | 2019 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
group | 0.400 | None | 0.959 | 0 | 0 | 1989 | 2019 | ||||||||
|
dicer 1, ribonuclease III | 0.446 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.959 | 0 | 0 | 2007 | 2020 | ||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.962 | 0 | 0 | 2004 | 2019 | ||||||||
|
ATR serine/threonine kinase | 0.456 | 0.923 | 3.5E-09 |
|
group | 0.400 | None | 0.965 | 0 | 0 | 1999 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
group | 0.400 | None | 0.966 | 0 | 0 | 1991 | 2020 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
group | 0.400 | None | 0.966 | 0 | 0 | 1995 | 2019 | ||||||||
|
AKT serine/threonine kinase 2 | 0.474 | 0.769 | 0.64 |
|
group | 0.400 | None | 0.966 | 0 | 0 | 2002 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.400 | None | 0.966 | 0 | 0 | 1986 | 2020 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.600 | None | 0.968 | 0 | 0 | 1993 | 2020 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
group | 0.400 | None | 0.968 | 0 | 0 | 1998 | 2019 |